Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma.

Dhabhar FS, Saul AN, Holmes TH, Daugherty C, Neri E, Tillie JM, Kusewitt D, Oberyszyn TM.

PLoS One. 2012;7(4):e33069. doi: 10.1371/journal.pone.0033069. Epub 2012 Apr 25.

2.

Chronic stress and susceptibility to skin cancer.

Saul AN, Oberyszyn TM, Daugherty C, Kusewitt D, Jones S, Jewell S, Malarkey WB, Lehman A, Lemeshow S, Dhabhar FS.

J Natl Cancer Inst. 2005 Dec 7;97(23):1760-7.

3.

Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma.

Dhabhar FS, Saul AN, Daugherty C, Holmes TH, Bouley DM, Oberyszyn TM.

Brain Behav Immun. 2010 Jan;24(1):127-37. doi: 10.1016/j.bbi.2009.09.004. Epub 2009 Sep 16.

4.

Vascular endothelial growth factor is a marker of tumor invasion and metastasis in squamous cell carcinomas of the head and neck.

Sauter ER, Nesbit M, Watson JC, Klein-Szanto A, Litwin S, Herlyn M.

Clin Cancer Res. 1999 Apr;5(4):775-82.

5.

[Expression of angiotensin II type 1 receptor in cervical squamous cell carcinoma and its clinical significance].

Liao YD, Xu H, Han Q, Lei J, Zhang YY, Wang ZH.

Zhonghua Zhong Liu Za Zhi. 2007 May;29(5):360-4. Chinese.

PMID:
17892132
6.
7.

Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.

Riedel F, Götte K, Hörmann K, Grandis JR.

Adv Otorhinolaryngol. 2005;62:103-20.

PMID:
15608422
8.

Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis.

von Marschall Z, Scholz A, Cramer T, Schäfer G, Schirner M, Oberg K, Wiedenmann B, Höcker M, Rosewicz S.

J Natl Cancer Inst. 2003 Mar 19;95(6):437-48.

9.

RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.

Feng Y, Hu J, Ma J, Feng K, Zhang X, Yang S, Wang W, Zhang J, Zhang Y.

Eur J Cancer. 2011 Oct;47(15):2353-63. doi: 10.1016/j.ejca.2011.05.006. Epub 2011 Jun 15.

PMID:
21680174
10.
11.

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis.

Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M.

J Exp Med. 2005 Apr 4;201(7):1089-99.

12.

[Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].

Han LF, Qiu WM, Hu C, Wang L, Yao HX, Xiong SY, Meng M, Fang Y, Ma D.

Zhonghua Fu Chan Ke Za Zhi. 2010 Aug;45(8):603-8. Chinese.

PMID:
21029617
13.

[Expression of vascular endothelial growth factor C in pancreatic cancer and its effect upon lymph node metastasis].

Li K, Li MJ, He T, Zheng Z, Zheng XL, Qu BH, Wang Y, Duan X, Zheng YJ.

Zhonghua Yi Xue Za Zhi. 2009 Sep 15;89(34):2386-90. Chinese.

PMID:
20137690
14.

Alterations in anxiety-like behavior following knockout of the uncoupling protein 2 (ucp2) gene in mice.

Gimsa U, Kanitz E, Otten W, Aheng C, Tuchscherer M, Ricquier D, Miroux B, Ibrahim SM.

Life Sci. 2011 Nov 7;89(19-20):677-84. doi: 10.1016/j.lfs.2011.08.009. Epub 2011 Aug 22.

PMID:
21878341
15.

Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.

Riedel F, Götte K, Li M, Hörmann K, Grandis JR.

Int J Oncol. 2003 Sep;23(3):577-83.

PMID:
12888890
16.

Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor.

Wei LH, Kuo ML, Chen CA, Cheng WF, Cheng SP, Hsieh FJ, Hsieh CY.

Gynecol Oncol. 2001 Jul;82(1):49-56.

PMID:
11426961
17.

Expression of angiostatic platelet factor-4var/CXCL4L1 counterbalances angiogenic impulses of vascular endothelial growth factor, interleukin-8/CXCL8, and stromal cell-derived factor 1/CXCL12 in esophageal and colorectal cancer.

Verbeke H, De Hertogh G, Li S, Vandercappellen J, Noppen S, Schutyser E, El-Asrar AA, Opdenakker G, Van Damme J, Geboes K, Struyf S.

Hum Pathol. 2010 Jul;41(7):990-1001. doi: 10.1016/j.humpath.2009.09.021. Epub 2010 Mar 23.

PMID:
20334899
19.

Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.

Komuro A, Yashiro M, Iwata C, Morishita Y, Johansson E, Matsumoto Y, Watanabe A, Aburatani H, Miyoshi H, Kiyono K, Shirai YT, Suzuki HI, Hirakawa K, Kano MR, Miyazono K.

J Natl Cancer Inst. 2009 Apr 15;101(8):592-604. doi: 10.1093/jnci/djp058. Epub 2009 Apr 7.

20.

The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.

Hanrahan V, Currie MJ, Gunningham SP, Morrin HR, Scott PA, Robinson BA, Fox SB.

J Pathol. 2003 Jun;200(2):183-94.

PMID:
12754739
Items per page

Supplemental Content

Write to the Help Desk